Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0V1HA
|
||||
| Former ID |
DNC013433
|
||||
| Drug Name |
N-hydroxy-3-(naphthalen-1-yl)acrylamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528719] | ||
| Formula |
C13H11NO2
|
||||
| Canonical SMILES |
C1=CC=C2C(=C1)C=CC=C2C=CC(=O)NO
|
||||
| InChI |
1S/C13H11NO2/c15-13(14-16)9-8-11-6-3-5-10-4-1-2-7-12(10)11/h1-9,16H,(H,14,15)/b9-8+
|
||||
| InChIKey |
AOXOYUCWJCCUDO-CMDGGOBGSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Histone Deacetylase 8 | Target Info | Inhibitor | [528719] | |
| KEGG Pathway | Alcoholism | ||||
| Viral carcinogenesis | |||||
| PANTHER Pathway | Wnt signaling pathway | ||||
| Pathway Interaction Database | Signaling events mediated by HDAC Class I | ||||
| References | |||||